help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Originally published online as doi:10.2353/ajpath.2008.071059 on June 26, 2008

Published online before print June 26, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ajpath.2008.071059v1
173/2/507    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gomez, J. C.
Right arrow Articles by Doerschuk, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gomez, J. C.
Right arrow Articles by Doerschuk, C. M.
(American Journal of Pathology. 2008;173:507-517.)
© 2008 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2008.071059

The Role of Rac2 in Regulating Neutrophil Production in the Bone Marrow and Circulating Neutrophil Counts

John C. Gomez*{dagger}, Jindrich Soltys*, Keiichi Okano*, Mary C. Dinauer{ddagger} and Claire M. Doerschuk*{dagger}

From the Department of Pediatrics,* Division of Integrative Biology, Rainbow Babies and Children’s Hospital and Case Western Reserve University, and the Department of Pathology,{dagger} Case Western Reserve University, Cleveland, Ohio; and the Cancer Research Institute,{ddagger} Indiana University School of Medicine, Indianapolis, Indiana

Circulating neutrophils are persistently higher in mice deficient in the small GTPase Rac2 than in wild-type (WT) mice. Therefore, we examined the mechanisms through which the small GTPase Rac2 regulates neutrophil production and release. Lethally irradiated WT mice reconstituted with a 50:50 mixture of WT and Rac2–/– fetal liver cells were protected from neutrophilia, suggesting that neutrophilia is primarily because of extrinsic defects that can be corrected by WT leukocytes. However, the differential counts and numbers of leukocyte subtypes differed between Rac2–/– and WT cells, suggesting that Rac2 modulates leukocyte lineage distribution. Kinetic studies suggest Rac2 modulates the release of neutrophils into the circulation and does not prolong their circulating half life. The percentage of bone marrow cells that expressed the neutrophil marker Gr-1 in lethally irradiated WT or Rac2–/– recipients of Rac2–/– stem cells was greater than in recipients of WT stem cells; however, circulating neutrophil counts were higher only in Rac2–/– recipients of Rac2–/– stem cells. Rac2 mRNA was expressed in the bone marrow of WT recipients of Rac2–/– stem cells and in human mesenchymal stem cells. The data presented here suggest that Rac2 in hematopoietic cells regulates leukocyte lineage distribution and Rac2 in nonhematopoietic cells might contribute to regulating circulating neutrophil counts.




This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
M. R. Distasi, J. Case, M. A. Ziegler, M. C. Dinauer, M. C. Yoder, L. S. Haneline, M. C. Dalsing, S. J. Miller, C. A. Labarrere, M. P. Murphy, et al.
Suppressed hindlimb perfusion in Rac2-/- and Nox2-/- mice does not result from impaired collateral growth
Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H877 - H886.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Society for Investigative Pathology.